NCT07457164 2026-03-12A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate CancerAntev Ltd.Phase 2 Not yet recruiting40 enrolled